Rare diseases
Investigational molecules
Locations
237 conditions with trials, the busiest first
741 trials across Europe, recruiting first
Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
HungaryComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
GermanyStudy of cagrilintide for weight reduction in adults with overweight or obesity when combined with lifestyle changes
FranceStudy of drug interactions between leriglitazone, gemfibrozil, itraconazole, and carbamazepine and food effects in healthy male volunteers for adrenoleukodystrophy treatment
PolandStudy of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels
DenmarkStudy of baxdrostat compared to placebo to treat adults with primary aldosteronism
FranceStudy of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)
BulgariaStudy on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes
ItalyStudy on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema
AustriaStudy on the Effects of Roxadustat and Placebo on Cardiovascular Risk Factors and Metabolic Syndrome in Patients
FinlandStudy on the Use of Indocyanine Green to Assess Lymphatic Vessel Porosity in Women with Lipedema
BelgiumStudy on the Effects and Safety of GLM101 for Patients with PMM2-CDG
BelgiumThe therapies tested most often in Metabolism and nutrition disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
